Overview

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence

Status:
Completed
Trial end date:
2016-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether: (1) the combination of N-acetylcysteine + high-dose naltrexone (150 mg) works better than high-dose naltrexone (150 mg) alone in reducing alcohol drinking; and (2) high-dose naltrexone (150 mg) alone works better than low-dose naltrexone (50 mg) alone in reducing alcohol drinking.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Acetylcysteine
N-monoacetylcystine
Naltrexone